Qube Research & Technologies (QRT)’s BioMarin Pharmaceuticals BMRN Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $35.2M | Buy |
+640,393
| New | +$35.2M | 0.04% | 414 |
|
2025
Q1 | – | Sell |
-6,576
| Closed | -$432K | – | 2748 |
|
2024
Q4 | $432K | Buy |
+6,576
| New | +$432K | ﹤0.01% | 2009 |
|
2024
Q3 | – | Sell |
-14
| Closed | -$1.15K | – | 2816 |
|
2024
Q2 | $1.15K | Sell |
14
-14,835
| -100% | -$1.22M | ﹤0.01% | 2854 |
|
2024
Q1 | $1.3M | Buy |
14,849
+4,319
| +41% | +$377K | ﹤0.01% | 1693 |
|
2023
Q4 | $1.02M | Sell |
10,530
-71,145
| -87% | -$6.86M | ﹤0.01% | 1637 |
|
2023
Q3 | $7.23M | Sell |
81,675
-407,530
| -83% | -$36.1M | 0.02% | 608 |
|
2023
Q2 | $42.4M | Buy |
489,205
+12,454
| +3% | +$1.08M | 0.15% | 179 |
|
2023
Q1 | $46.4M | Buy |
476,751
+211,481
| +80% | +$20.6M | 0.2% | 91 |
|
2022
Q4 | $27.5M | Buy |
265,270
+169,933
| +178% | +$17.6M | 0.15% | 172 |
|
2022
Q3 | $8.08M | Buy |
+95,337
| New | +$8.08M | 0.05% | 433 |
|
2022
Q2 | – | Sell |
-268,780
| Closed | -$20.7M | – | 2506 |
|
2022
Q1 | $20.7M | Buy |
+268,780
| New | +$20.7M | 0.18% | 140 |
|
2021
Q4 | – | Sell |
-24,205
| Closed | -$1.87M | – | 2537 |
|
2021
Q3 | $1.87M | Buy |
24,205
+10,252
| +73% | +$792K | 0.02% | 699 |
|
2021
Q2 | $1.16M | Buy |
13,953
+3,197
| +30% | +$267K | 0.01% | 873 |
|
2021
Q1 | $812K | Buy |
+10,756
| New | +$812K | 0.01% | 931 |
|
2020
Q4 | – | Sell |
-52,118
| Closed | -$3.97M | – | 1817 |
|
2020
Q3 | $3.97M | Buy |
52,118
+45,906
| +739% | +$3.49M | 0.06% | 431 |
|
2020
Q2 | $766K | Buy |
+6,212
| New | +$766K | 0.01% | 954 |
|
2019
Q3 | – | Sell |
-6,387
| Closed | -$547K | – | 262 |
|
2019
Q2 | $547K | Buy |
6,387
+2,334
| +58% | +$200K | 0.13% | 169 |
|
2019
Q1 | $360K | Buy |
+4,053
| New | +$360K | 0.05% | 365 |
|
2018
Q4 | – | Sell |
-2,704
| Closed | -$262K | – | 363 |
|
2018
Q3 | $262K | Buy |
+2,704
| New | +$262K | 0.03% | 395 |
|